As a prospective cancer treatment, extracts and phytochemicals of maqui berries were commonly described as anti-angiogenic, and 10 μM of delphinidin were shown to hamper HUVEC tube formation via the inhibition of VEGFR2 downstream signaling [35,36,67]. The gene discussed is KDR; the disease is cancer.